BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6551372)

  • 1. Correction of ascites with peritoneovenous shunting: a study of clinical management.
    Schumann D
    Heart Lung; 1983 May; 12(3):248-55. PubMed ID: 6551372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient selection and survival after peritoneovenous shunting for nonmalignant ascites.
    Smith RE; Nostrant TT; Eckhauser FE; Wilson JP; Knol JA; Strodel WE
    Am J Gastroenterol; 1984 Aug; 79(8):659-62. PubMed ID: 6465114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of ascites. A review.
    Watanabe A
    J Med; 1997; 28(1-2):21-30. PubMed ID: 9249607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneovenous shunting for intractable ascites.
    Gullstrand P; Alwmark A; Börjesson B; Joelsson B; Bengmark S
    Scand J Gastroenterol; 1982 Nov; 17(8):1009-12. PubMed ID: 7167735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [12-year experience with continuous peritoneovenous shunt in the treatment of therapy-resistant ascites and hepatorenal failure: benefits and pitfalls].
    Kreuzer W
    Wien Klin Wochenschr; 1989 Jan; 101(2):87-91. PubMed ID: 2916345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hemorrhagic syndrome caused by peritoneovenous shunt with a flow regulation device].
    Violi V; Montanari M; Roncoroni L
    G Chir; 1990; 11(7-8):413-5. PubMed ID: 2282274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of peritoneovenous shunting in unravelling the pathogenesis of ascites in cirrhosis.
    Blendis LM
    Isr J Med Sci; 1986 Feb; 22(2):78-80. PubMed ID: 3512475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Denver shunt in malignant ascites].
    Van Damme H; Vaneerdeweg W; Schoofs E
    Acta Chir Belg; 1985; 85(1):43-52. PubMed ID: 2580408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cirrhotic ascites: pathogenesis and management.
    Garcia-Tsao G
    Gastroenterologist; 1995 Mar; 3(1):41-54. PubMed ID: 7743121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascites.
    Neighbor ML
    Emerg Med Clin North Am; 1989 Aug; 7(3):683-97. PubMed ID: 2663463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The peritoneovenous shunt: expectations and reality.
    Moskovitz M
    Am J Gastroenterol; 1990 Aug; 85(8):917-29. PubMed ID: 2197858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of refractory ascites by means of the LeVeen shunt].
    Gonvers JJ; Loup P; Brunner HR; Mosimann R; Hofstetter JR
    Schweiz Med Wochenschr; 1981 Feb; 111(7):220-3. PubMed ID: 7013063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful treatment for intractable ascites with uterine cancer using double Denver peritoneovenous shunt system].
    Kawamoto J; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Nozawa S; Furukawa K; Mitsuhashi N; Takeuchi D; Suda K; Yoshioka I; Miyazaki M
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1919-23. PubMed ID: 17212147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal and hemodynamic effects of the peritoneovenous shunt. II. Long-term effects.
    Greig PD; Blendis LM; Langer B; Taylor BR; Colapinto RF
    Gastroenterology; 1981 Jan; 80(1):119-25. PubMed ID: 7004991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of LeVeen shunting in refractory ascites--a view from the other side.
    Grischkan DM; Cooperman AM; Hermann RE; Carey WD; Ferguson DR; Cook SA
    Surgery; 1981 Mar; 89(3):304-8. PubMed ID: 7466618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of peritoneovenous shunt for malignant ascites.
    Lokich J; Reinhold R; Silverman M; Tullis J
    Cancer Treat Rep; 1980; 64(2-3):305-9. PubMed ID: 6157465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peritovenous shunt (Denver Shunt) in therapy resistant ascites in childhood].
    Teufel M; Reifferscheid P; Niessen KH
    Monatsschr Kinderheilkd; 1983 Sep; 131(9):603-6. PubMed ID: 6621573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saphenoperitoneal shunts for patients with intractable ascites associated with chronic liver disease.
    Vadeyar HJ; Doran JD; Charnley R; Ryder SD
    Br J Surg; 1999 Jul; 86(7):882-5. PubMed ID: 10417558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneovenous shunting for intractable ascites.
    Tyden G; Samnegård H; Thulin L
    Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneovenous shunt for palliation of malignant ascites.
    Qazi R; Savlov ED
    Cancer; 1982 Feb; 49(3):600-2. PubMed ID: 6174196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.